Thesis

Real-time determination of active pharmaceutical ingredient solubility in polymer matrices and solid-state monitoring using in situ terahertz (THz)-Raman spectroscopy during extrusion

Creator
Rights statement
Awarding institution
  • University of Strathclyde
Date of award
  • 2025
Thesis identifier
  • T17453
Person Identifier (Local)
  • 201986596
Qualification Level
Qualification Name
Department, School or Faculty
Abstract
  • This thesis aimed to develop and demonstrate the application of in situ terahertz(THz)-Raman spectroscopy as a real-time monitoring tool for determining activepharmaceutical ingredient (API) solubility in a polymer matrix during extrusion.Initially, a qualitative analysis was conducted to assess API solubility during theextrusion of a ternary system consisting of mefenamic acid, sorbitol, and Soluplus. Asolubility diagram was constructed using preprocessed in situ THz-Raman spectra,and off-line characterisation techniques confirmed the absence of crystallinity in theextrudates. The maximum API solubility was established at 15% w/w.Building on these findings, the thesis progressed to semi-quantitative analyses usingmultivariate curve resolution-alternating least squares (MCR-ALS) to quantify theratios of amorphous and crystalline API components during extrusion. MCR-ALS wasapplied successfully to two binary systems and a more complex ternary system. Theoptimised MCR parameters derived from the first binary system were transferable tothe subsequent systems, providing chemically meaningful results. Moreover, use ofreference spectra as a constraint did not show any advantage, confirming theeffectiveness of MCR-ALS as a calibration-free method for resolving in situ THzRaman spectra obtained during extrusion. Notably, the high sensitivity of MCR-ALSto crystalline content was demonstrated by the close match between experimentaland reconstructed spectra at higher drug loadings. Finally, the insights from earlierchapters were applied to the case study in collaboration with Eli Lilly and company.The high drug-loaded amorphous solid dispersions (HASDs) containing evacetrapibwere successfully formulated with 50% w/w API in the most suitable polymer, i.e.,Soluplus. Off-line characterisation confirmed the absence of crystallinity in both freshand 3-month-old extrudates, indicating the successful formulation of stable HASDs.The in situ and off-line characterisation techniques were largely in agreement.In conclusion, this research highlights the impact of in situ THz-Raman spectroscopyand MCR-ALS in pharmaceutical manufacturing, enabling real-time solid-statemonitoring, formulation design, and process control. These findings establish afoundation for broader applications of process analytical technology, with potentialbenefits beyond extrusion in drug development and production efficiency.
Advisor / supervisor
  • Nordon, Alison
  • Halbert, Gavin
  • Robertson, John
Resource Type
Note
  • Previously held under moratorium from 3 September 2025 until 3 March 2026.
DOI
Funder
Embargo Note
  • This thesis is restricted to Strathclyde users only until 3 September 2030

Relations

Items